Published in Oncogene on March 07, 2002
The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol (2004) 2.70
Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium (2009) 1.65
REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther (2010) 1.19
Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem (2011) 0.98
Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry (2005) 0.98
Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol (2007) 0.93
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Br J Pharmacol (2012) 0.80
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. Br J Cancer (2003) 0.80
Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med (2007) 0.80
Two Birds with One Stone: Possible Dual-Role of Oxytocin in the Treatment of Diabetes and Osteoporosis. Front Endocrinol (Lausanne) (2015) 0.79
Progesterone inhibits oxytocin- and prostaglandin F2alpha-stimulated increases in intracellular calcium concentrations in small and large ovine luteal cells. Biol Reprod (2009) 0.78
Long chain polyunsaturated fatty acids alter oxytocin signaling and receptor density in cultured pregnant human myometrial smooth muscle cells. PLoS One (2012) 0.78
Activation of an alpha2A-adrenoceptor-Galphao1 fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor. Biochem J (2005) 0.78
Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β-Arrestin-Independent Internalisation. J Neuroendocrinol (2016) 0.77
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (2003) 6.66
Formation of stacked ER cisternae by low affinity protein interactions. J Cell Biol (2003) 3.76
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A (2004) 2.44
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry (2011) 2.25
Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J (2009) 1.78
Endoplasmic reticulum architecture: structures in flux. Curr Opin Cell Biol (2006) 1.75
Assessing the tendency of fluorescent proteins to oligomerize under physiologic conditions. Traffic (2012) 1.49
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res (2008) 1.43
Transmembrane domain-dependent partitioning of membrane proteins within the endoplasmic reticulum. J Cell Biol (2008) 1.38
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors. J Neurooncol (2011) 1.31
G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol (2009) 1.31
Mechanisms underlying the neuronal calcium sensor-1-evoked enhancement of exocytosis in PC12 cells. J Biol Chem (2002) 1.28
Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes. J Biol Chem (2003) 1.27
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol (2012) 1.26
Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci (2010) 1.18
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem (2003) 1.15
Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. PLoS One (2010) 1.14
A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J (2009) 1.13
MET mutations in cancers of unknown primary origin (CUPs). Hum Mutat (2010) 1.13
The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J Biol Chem (2005) 1.11
Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system. J Cell Sci (2002) 1.10
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer. J Thorac Oncol (2009) 1.10
Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transl Med (2012) 1.08
Systemic cancer metastasis in a meningioma: report of two cases and review of the literature. Clin Neurol Neurosurg (2008) 1.08
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology). J Neurooncol (2013) 1.07
Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch (2006) 1.07
Synaptobrevin2-expressing vesicles in rat astrocytes: insights into molecular characterization, dynamics and exocytosis. J Physiol (2005) 1.06
Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling. Mol Pharmacol (2004) 1.03
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids. Proc Natl Acad Sci U S A (2005) 1.03
Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene (2003) 1.00
Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1. Eur J Neurosci (2006) 0.99
Dynamic and reversible restructuring of the ER induced by PDMP in cultured cells. J Cell Sci (2006) 0.99
Defective secretion of islet hormones in chromogranin-B deficient mice. PLoS One (2010) 0.99
Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem (2011) 0.98
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans. FASEB J (2003) 0.98
Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle". Am J Physiol Endocrinol Metab (2009) 0.98
Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol (2006) 0.98
Neuronal calcium sensor 1 and phosphatidylinositol 4-OH kinase beta interact in neuronal cells and are translocated to membranes during nucleotide-evoked exocytosis. J Cell Sci (2002) 0.97
Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J Cell Sci (2010) 0.96
Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease. Circ Cardiovasc Genet (2009) 0.96
Obstructive colon metastases from lobular breast cancer: report of a case and review of the literature. Tumori (2012) 0.96
MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors. J Neurooncol (2012) 0.95
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology (2002) 0.93
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature. Blood (2010) 0.92
Oxytocin receptor signaling in myoepithelial and cancer cells. J Mammary Gland Biol Neoplasia (2005) 0.92
Recurrence after transanal endoscopic microsurgery for large rectal adenomas. Surg Endosc (2012) 0.92
A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol Med (2012) 0.91
Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo. Transl Oncol (2011) 0.90
TI-VAMP/VAMP7 is the SNARE of secretory lysosomes contributing to ATP secretion from astrocytes. Biol Cell (2012) 0.90
Surgical scar endometriosis. Surg Today (2013) 0.90
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys (2009) 0.90
Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes (2004) 0.89
Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity. EMBO J (2013) 0.89
Effects of cholesterol manipulation on the signaling of the human oxytocin receptor. Am J Physiol Regul Integr Comp Physiol (2006) 0.89
Perianal granular cell tumor: report of a case and review of the literature. Tumori (2009) 0.88
Laparoscopic versus open resection for transverse colon cancer. Surg Endosc (2014) 0.88
Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish. Psychopharmacology (Berl) (2011) 0.88
MGMT promoter hypermethylation in a series of 104 glioblastomas. Cancer Genomics Proteomics (2009) 0.88
Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres. J Oncol (2011) 0.88
Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates. Am J Pathol (2003) 0.87
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol (2003) 0.87
Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor. J Neurochem (2010) 0.86
Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases. Acta Neuropathol (2009) 0.85
Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab (2005) 0.85
Role of positron emission tomography-computed tomography in the management of anal cancer. Int J Radiat Oncol Biol Phys (2012) 0.85
Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS. Mol Cell Neurosci (2012) 0.84
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. J Pathol (2012) 0.84
Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons. Mol Cell Neurosci (2012) 0.84
Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas. J Neuropathol Exp Neurol (2009) 0.84
Neuronal calcium sensor-1 binds to regulated secretory organelles and functions in basal and stimulated exocytosis in PC12 cells. J Cell Sci (2002) 0.84
Metastatic lymph node ratio as a prognostic factor after laparoscopic total mesorectal excision for extraperitoneal rectal cancer. Surg Endosc (2012) 0.84
Caveolin-1 as a promoter of tumour spreading: when, how, where and why. J Cell Mol Med (2013) 0.84
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. Am J Surg Pathol (2013) 0.83
Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat (2003) 0.83
Restructured endoplasmic reticulum generated by mutant amyotrophic lateral sclerosis-linked VAPB is cleared by the proteasome. J Cell Sci (2012) 0.83
Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol (2009) 0.83
A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors. J Neuropathol Exp Neurol (2013) 0.82
Late recurrence of Wilms' tumour with exclusive skeletal muscle phenotype 23 years after primary diagnosis. Virchows Arch (2006) 0.82
A cell surface biotinylation assay to reveal membrane-associated neuronal cues: Negr1 regulates dendritic arborization. Mol Cell Proteomics (2013) 0.82
Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas. Fertil Steril (2010) 0.82
Early oxidative damage in primary cultured trout hepatocytes: a time course study. Aquat Toxicol (2002) 0.82
Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue. J Cell Mol Med (2008) 0.82
Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors. J Pharmacol Exp Ther (2013) 0.81
CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem Pharmacol (2004) 0.81
Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GN11 and gonadotropin-releasing hormone-secreting GT1-7 neuronal cells. Neurochem Res (2002) 0.81
Low Foxp3 expression in negative sentinel lymph nodes is associated with node metastases in colorectal cancer. Gut (2010) 0.81
"Benign" metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung. Virchows Arch (2007) 0.81
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART). Med Oncol (2013) 0.81
Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med (2007) 0.80
LIN7 mediates the recruitment of IRSp53 to tight junctions. Traffic (2008) 0.80
Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level. Biochim Biophys Acta (2004) 0.80
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis. Fertil Steril (2012) 0.80